Maxzide and Lovenox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxzide (hydrochlorothiazide; triamterene) and Lovenox (enoxaparin sodium). Common drug interactions include cerebrovascular accident among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Maxzide and Lovenox. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Maxzide?

Maxzide has active ingredients of hydrochlorothiazide; triamterene. It is often used in high blood pressure. eHealthMe is studying from 9,152 Maxzide users. Check the latest studies of Maxzide.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.



On Jul, 12, 2026

76 people who take Maxzide and Lovenox together, and have interactions are studied.

Maxzide and Lovenox drug interactions.

What are the common drug interactions of Maxzide and Lovenox, by gender? *:

female:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Depression
  3. Diarrhoea
  4. Pneumonia
  5. Urinary tract infection
  6. Atelectasis (partial or complete collapse of the lung)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Chronic kidney disease
  9. Decreased appetite
  10. Dizziness

male:

  1. Diarrhoea
  2. Dehydration (dryness resulting from the removal of water)
  3. Pneumonia
  4. Dyspnoea (difficult or laboured respiration)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Pain
  7. Pyrexia (fever)
  8. Visual acuity reduced (reduced clearness of vision)
  9. Abdominal pain
  10. Albumin globulin ratio decreased

What are the common drug interactions of Maxzide and Lovenox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Attention deficit/hyperactivity disorder
  2. Disturbance in attention
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  4. Psychomotor hyperactivity (feelings of extreme restlessness)
  5. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

20-29:

n/a

30-39:

  1. Blindness unilateral
  2. Blood glucose increased
  3. Burning sensation
  4. Chest pain
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  7. Decreased appetite
  8. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  9. Dyspnoea (difficult or laboured respiration)
  10. Fall

40-49:

  1. Abdominal pain
  2. Albumin globulin ratio decreased
  3. Angioedema (rapid swelling of the dermis)
  4. Bacterial test positive
  5. Blood albumin increased
  6. Blood calcium increased
  7. Blood chloride increased
  8. Blood glucose increased
  9. Blood immunoglobulin a increased
  10. Blood iron decreased

50-59:

  1. Ankle fracture
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Balance disorder
  5. Benign neoplasm of skin (benign (non-cancerous) tumours of the skin)
  6. Blood glucose increased
  7. Bone decalcification
  8. Bone density decreased
  9. Cerumen impaction
  10. Chronic kidney disease

60+:

  1. Diarrhoea
  2. Dehydration (dryness resulting from the removal of water)
  3. Rash
  4. Urinary tract infection
  5. Atelectasis (partial or complete collapse of the lung)
  6. Cough
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  8. Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
  9. Injury
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Diabetes: 10 people, 13.16%
  2. Pain: 9 people, 11.84%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 9.21%
  4. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 5 people, 6.58%
  5. Multiple Myeloma (cancer of the plasma cells): 5 people, 6.58%
  6. Hypersensitivity: 5 people, 6.58%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 6.58%
  8. Depression: 5 people, 6.58%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 6.58%
  10. Stress And Anxiety: 4 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Maxzide and Lovenox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Maxzide and Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Maxzide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxzide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; triamterene and enoxaparin sodium (the active ingredients of Maxzide and Lovenox, respectively), and Maxzide and Lovenox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: